Titan Medical (CVE:TMD) said this week that it licensed “know-how and certain technology” from Mayo Clinic for its Sport robot-assisted surgery platform.
The license covers intellectual property developed by Dr. David Larson, chairman of the colorectal surgery department at the Rochester, Minn.-based clinic, “including that developed through his participation in cadaver studies with Titan’s Sport surgical system,” Titan said.
“We are very excited to further develop procedures, know-how and instruments for colorectal surgery as we move even closer to the commercialization of the Sport surgical system,” chairman & CEO John Hargrove said in prepared remarks.
Last month was busy for Titan, with the closing of a $4 million private placement with Longtai, the Canadian subsidiary of China’s Ningbo Long Hengtai International Trade Co. The Toronto-based company also inked a deal with Cadence Device for instruments for the Sport system.